FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Feigin

Research Profile

Disorders

Anatomy

Procedures

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Physiology

Learning

Co-author Network

Publications

TOP 3
Martin Niethammer; Andrew Feigin; David Eidelberg
Functional neuroimaging in Parkinson's disease.
Antonios Mammis; Andrew Feigin; Michael Pourfar; Alon Y Mogilner
Deep brain stimulation for the treatment of tremor and ataxia associated with abetalipoproteinemia.
Andrew Feigin
Pridopidine in treatment of Huntington's disease: beyond chorea?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Feigin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Martin Niethammer; Andrew Feigin; David Eidelberg
Functional neuroimaging in Parkinson's disease.
Cold Spring Harbor perspectives in medicine 2012;2(5):a009274.
2012: Antonios Mammis; Andrew Feigin; Michael Pourfar; Alon Y Mogilner
Deep brain stimulation for the treatment of tremor and ataxia associated with abetalipoproteinemia.
Tremor and other hyperkinetic movements (New York, N.Y.) 2012;2():.
2011: Andrew Feigin
Pridopidine in treatment of Huntington's disease: beyond chorea?
Lancet neurology 2011;10(12):1036-7.
2011: Clara Moisello; Bernardo Perfetti; Vittorio Sanguineti; Lucio Marinelli; Marco Bove; Alessandro Di Rocco; David Eidelberg; Andrew Feigin; Maria Felice Ghilardi
Basal ganglia and kinematics modulation: insights from Parkinson's and Huntington's diseases.
Parkinsonism & related disorders 2011;17(8):642-4.
2011: Michael Pourfar; Andrew Feigin; C C Tang; M Carbon-Correll; M Bussa; C Budman; Vijay Dhawan; David Eidelberg
Abnormal metabolic brain networks in Tourette syndrome.
Neurology 2011;76(11):944-52.
2010: Yilong Ma; Chaorui Huang; Jonathan P Dyke; Hong Pan; David Alsop; Andrew Feigin; David Eidelberg
Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2010;30(3):505-9.
2010: Karl Kieburtz; Michael P McDermott; Tiffini S Voss; Jody Corey-Bloom; Lisa M Deuel; E Ray Dorsey; Stewart A Factor; Michael D Geschwind; Karen Hodgeman; Elise Kayson; Sarah Noonberg; Michael Pourfar; Karen Rabinowitz; Bernard Ravina; Juan Sanchez-Ramos; Lynn Seely; Francis Walker; Andrew Feigin
A randomized, placebo-controlled trial of latrepirdine in Huntington disease.
Archives of neurology 2010;67(2):154-60.
2010: Chris C Tang; Kathleen L Poston; Thomas Eckert; Andrew Feigin; Steven Frucht; Mark Gudesblatt; Vijay Dhawan; Martin Lesser; Jean-Paul Vonsattel; Stanley Fahn; David Eidelberg
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis.
Lancet neurology 2010;9(2):149-58.
2009: Michael Pourfar; Andrew Feigin
The numb and the restless: peripheral neuropathy and RLS.
Neurology 2009;72(11):950-1.
2008: Miklos Argyelan; Maren Carbon; Maria Felice Ghilardi; Andrew Feigin; Paul Mattis; Chengke Tang; Vijay Dhawan; David Eidelberg
Dopaminergic suppression of brain deactivation responses during sequence learning.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(42):10687-95.
2008: Maria Felice Ghilardi; G Silvestri; Andrew Feigin; Paul Mattis; Dennis J Zgaljardic; C Moisello; D Crupi; L Marinelli; A Dirocco; David Eidelberg
Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease.
Parkinsonism & related disorders 2008;14(6):457-64.
2007: Andrew Feigin; Michael Gordon Kaplitt; Chengke Tang; Tanya Lin; Paul Mattis; Vijay Dhawan; Matthew J During; David Eidelberg
Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(49):19559-64.
2007: Andrew Feigin; Chengke Tang; Yilong Ma; Paul Mattis; Dennis J Zgaljardic; M Guttman; Jane S Paulsen; Vijay Dhawan; David Eidelberg
Thalamic metabolism and symptom onset in preclinical Huntington's disease.
Brain : a journal of neurology 2007;130(Pt 11):2858-67.
2007: Dennis J Zgaljardic; Joan C Borod; Nancy S. Foldi Ph.D.; Mary Rocco; Paul Mattis; Mark F Gordon; Andrew Feigin; David Eidelberg
Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease.
Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2007;20(3):184-92.
2007: Andrew Feigin; David Eidelberg
Gene transfer therapy for neurodegenerative disorders.
Movement disorders : official journal of the Movement Disorder Society 2007;22(9):1223-8; quiz 1369.
2007: Chaorui Huang; Chengke Tang; Andrew Feigin; Martin Lesser; Yilong Ma; Michael Pourfar; Vijay Dhawan; David Eidelberg
Changes in network activity with the progression of Parkinson's disease.
Brain : a journal of neurology 2007;130(Pt 7):1834-46.
2007: Michael Gordon Kaplitt; Andrew Feigin; Chengke Tang; Helen L Fitzsimons; Paul Mattis; Patricia A Lawlor; Ross J Bland; Deborah Young; Kristin Strybing; David Eidelberg; Matthew J During
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.
Lancet 2007;369(9579):2097-105.
2007: Maria Felice Ghilardi; Andrew Feigin; Fortunato Battaglia; Giulia Silvestri; Paul Mattis; David Eidelberg; Alessandro Di Rocco
L-Dopa infusion does not improve explicit sequence learning in Parkinson's disease.
Parkinsonism & related disorders 2007;13(3):146-51.
2007: Thomas Eckert; Andrew Feigin; Daniel E Lewis; Vijay Dhawan; Steven Frucht; David Eidelberg
Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging.
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):167-73.
2006: Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael Gordon Kaplitt; Andrew Feigin; David Eidelberg
Network modulation in the treatment of Parkinson's disease.
Brain : a journal of neurology 2006;129(Pt 10):2667-78.
2006: Dennis J Zgaljardic; Joan C Borod; Nancy S. Foldi Ph.D.; Paul Mattis; Mark F Gordon; Andrew Feigin; David Eidelberg
An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease.
Journal of clinical and experimental neuropsychology 2006;28(7):1127-44.
2006: Andrew Feigin; Maria Felice Ghilardi; Chaorui Huang; Yilong Ma; Maren Carbon; Mark Guttman; Jane S Paulsen; Claude Ghez; David Eidelberg
Preclinical Huntington's disease: compensatory brain responses during learning.
Annals of neurology 2006;59(1):53-9.
2005: Thomas Eckert; Anna Barnes; Vijay Dhawan; Steven Frucht; Mark F Gordon; Andrew Feigin; David Eidelberg
FDG PET in the differential diagnosis of parkinsonian disorders.
NeuroImage 2005;26(3):912-21.
2004: Andrew Feigin
Evidence from biomarkers and surrogate endpoints.
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 2004;1(3):323-30.
2004: Dennis J Zgaljardic; Andrew Feigin
Neuroimaging of Parkinson's disease and atypical parkinsonism.
Current neurology and neuroscience reports 2004;4(4):284-9.
2003: Marc J Mentis; Vijay Dhawan; Andrew Feigin; Dominique Delalot; Dennis J Zgaljardic; Christine Edwards; David Eidelberg
Early stage Parkinson's disease patients and normal volunteers: comparative mechanisms of sequence learning.
Human brain mapping 2003;20(4):246-58.
2003: Maren Carbon; Maria Felice Ghilardi; Andrew Feigin; Masafumi Fukuda; Giulia Silvestri; Marc J Mentis; Claude Ghez; James R Moeller; David Eidelberg
Learning networks in health and Parkinson's disease: reproducibility and treatment effects.
Human brain mapping 2003;19(3):197-211.
2003: Andrew Feigin; Maria Felice Ghilardi; Maren Carbon; Christine Edwards; M Fukuda; Vijay Dhawan; Claude Margouleff; Claude Ghez; David Eidelberg
Effects of levodopa on motor sequence learning in Parkinson's disease.
Neurology 2003;60(11):1744-9.
2003: Marc J Mentis; Vijay Dhawan; T Nakamura; Maria Felice Ghilardi; Andrew Feigin; C Edwards; Claude Ghez; David Eidelberg
Enhancement of brain activation during trial-and-error sequence learning in early PD.
Neurology 2003;60(4):612-9.
2002: Andrew Feigin; Angelo Antonini; Masafumi Fukuda; Roberta de Notaris; Riccardo Benti; Gianni Pezzoli; Marc J Mentis; James R Moeller; David Eidelberg
Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2002;17(6):1265-70.
2002: Masafumi Fukuda; Maria Felice Ghilardi; Maren Carbon; Vijay Dhawan; Yilong Ma; Andrew Feigin; Marc J Mentis; Claude Ghez; David Eidelberg
Pallidal stimulation for parkinsonism: improved brain activation during sequence learning.
Annals of neurology 2002;52(2):144-52.
2002: Andrew Feigin; Dennis J Zgaljardic
Recent advances in Huntington's disease: implications for experimental therapeutics.
Current opinion in neurology 2002;15(4):483-9.
2002: Andrew Feigin; Maria Felice Ghilardi; M Fukuda; Marc J Mentis; Vijay Dhawan; A Barnes; Claude Ghez; David Eidelberg
Effects of levodopa infusion on motor activation responses in Parkinson's disease.
Neurology 2002;59(2):220-6.
2002: Marc J Mentis; Anthony R McIntosh; Kenneth Perrine; Vijay Dhawan; Brian Berlin; Andrew Feigin; Christine Edwards; Paul Mattis; David Eidelberg
Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease.
The American journal of psychiatry 2002;159(5):746-54.
2001: Andrew Feigin; M Fukuda; Vijay Dhawan; Serge Przedborski; Vernice Jackson-Lewis; Marc J Mentis; James R Moeller; David Eidelberg
Metabolic correlates of levodopa response in Parkinson's disease.
Neurology 2001;57(11):2083-8.
2001: Andrew Feigin; Klaus L Leenders; James R Moeller; J Missimer; G Kuenig; Phoebe Spetsieris; Angelo Antonini; David Eidelberg
Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(11):1591-5.
1998: Angelo Antonini; K Kazumata; Andrew Feigin; F Mandel; Vijay Dhawan; Claude Margouleff; David Eidelberg
Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.
Movement disorders : official journal of the Movement Disorder Society 1998;13(2):268-74.
1997: David Eidelberg; James R Moeller; Angelo Antonini; K Kazumata; Vijay Dhawan; Cathy L Budman; Andrew Feigin
The metabolic anatomy of Tourette's syndrome.
Neurology 1997;48(4):927-34.